Pharmacists learned about the emerging use of real world evidence and its application in drug and vaccine approvals. In addition, pharmacists found out more about the different technologies in the manufacturer of influenza vaccinations especially in adults 65 years of age and older. They also found out about new approaches to vaccine production and vaccinations with lessons learned from COVID-19 vaccinations.